alpha-Hydroxy Acid [EPC]

alpha-Hydroxy Acid [EPC] was reported 2181 times

Drugs of the alpha-Hydroxy Acid [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 HETEROGENEOUSLY DENSE BREASTS 2 0.2500
1 SKIN HYPERPLASIA 3 0.0526
2 BLOOD HYPOSMOSIS 2 0.0500
3 MAGNESIUM METABOLISM DISORDER 2 0.0408
4 SYSTOLIC ANTERIOR MOTION OF MITRAL VALVE 3 0.0357
5 KERATOSIS FOLLICULAR 2 0.0256
6 FACIAL OPERATION 4 0.0248
7 INTRACARDIAC PRESSURE INCREASED 2 0.0227
8 NEUROFIBROMA 2 0.0133
9 BONE METABOLISM DISORDER 4 0.0133
10 NAEVUS FLAMMEUS 2 0.0128
11 CEREBRAL AMYLOID ANGIOPATHY 4 0.0121
12 KERATOSIS PILARIS 3 0.0120
13 BORDERLINE GLAUCOMA 2 0.0108
14 HEPATITIS B ANTIBODY POSITIVE 2 0.0106
15 SKIN ULCER HAEMORRHAGE 4 0.0104
16 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 11 0.0104
17 DEAFNESS PERMANENT 2 0.0102
18 HEPATITIS A ANTIBODY POSITIVE 2 0.0101
19 CARDIAC FAILURE HIGH OUTPUT 2 0.0083
20 HYPERPARATHYROIDISM SECONDARY 18 0.0072
21 CHONDROMALACIA 2 0.0070
22 LENTIGO 3 0.0060
23 CHRONIC RESPIRATORY DISEASE 2 0.0057
24 NEPHROGENIC ANAEMIA 24 0.0052
25 CHRONIC HEPATITIS C 2 0.0051
26 BONE DEMINERALISATION 5 0.0047
27 MITRAL VALVE CALCIFICATION 3 0.0047
28 HAEMANGIOMA OF SKIN 2 0.0046
29 STASIS DERMATITIS 3 0.0044
30 NECROTISING OESOPHAGITIS 2 0.0040
31 CAPILLARY FRAGILITY 2 0.0039
32 CORONAVIRUS TEST POSITIVE 4 0.0039
33 ESSENTIAL HYPERTENSION 7 0.0038
34 GALLBLADDER ENLARGEMENT 4 0.0037
35 GENITAL DISCOMFORT 2 0.0036
36 MEAN CELL HAEMOGLOBIN CONCENTRATION INCREASED 2 0.0036
37 CONGENITAL CYSTIC KIDNEY DISEASE 3 0.0035
38 ELECTRIC SHOCK 3 0.0035
39 NEURODERMATITIS 12 0.0032
40 FRACTURED SACRUM 4 0.0032
41 END STAGE RENAL DISEASE 55 0.0030
42 BLOOD FOLATE DECREASED 2 0.0028
43 RENAL TUBULAR ACIDOSIS 6 0.0027
44 ECONOMIC PROBLEM 37 0.0024
45 ARTHROPOD STING 4 0.0024
46 COVID-19 IMMUNISATION 2 0.0024
47 CUTANEOUS T-CELL LYMPHOMA 3 0.0024
48 HYPERKERATOSIS 13 0.0024
49 HIRSUTISM 3 0.0023
50 ANAEMIA OF CHRONIC DISEASE 2 0.0022
51 CERUMEN IMPACTION 2 0.0022
52 HAEMOCHROMATOSIS 2 0.0022
53 NAIL INFECTION 3 0.0021
54 FALSE POSITIVE INVESTIGATION RESULT 2 0.0020
55 ANHEDONIA 52 0.0020
56 APPLICATION SITE DISCOLOURATION 8 0.0020
57 BRAIN DEATH 6 0.0019
58 HYPERTROPHIC CARDIOMYOPATHY 3 0.0019
59 SCLERODERMA 7 0.0019
60 ELECTROCARDIOGRAM T WAVE ABNORMAL 3 0.0019
61 INTERVERTEBRAL DISC COMPRESSION 2 0.0019
62 BURNS THIRD DEGREE 2 0.0019
63 SKIN DISCOMFORT 5 0.0019
64 COLONIC POLYP 3 0.0018
65 TONSILLAR HYPERTROPHY 3 0.0018
66 SKIN HYPERTROPHY 5 0.0018
67 METABOLIC SURGERY 2 0.0018
68 GROIN ABSCESS 2 0.0017
69 CHRONIC KIDNEY DISEASE 127 0.0017
70 CHRONIC RESPIRATORY FAILURE 2 0.0017
71 REBOUND ACID HYPERSECRETION 5 0.0017
72 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 4 0.0016
73 POST-ACUTE COVID-19 SYNDROME 2 0.0016
74 BLOOD IMMUNOGLOBULIN G DECREASED 4 0.0016
75 PRE-EXISTING CONDITION IMPROVED 10 0.0016
76 ANION GAP INCREASED 2 0.0015
77 BODY MASS INDEX INCREASED 2 0.0015
78 EYELID PAIN 3 0.0015
79 INFUSION SITE RASH 2 0.0015
80 DISCHARGE 2 0.0014
81 ELECTRIC SHOCK SENSATION 4 0.0014
82 ATRIAL TACHYCARDIA 3 0.0014
83 OBSTRUCTIVE SLEEP APNOEA SYNDROME 2 0.0014
84 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 23 0.0014
85 CHRONIC SINUSITIS 5 0.0013
86 DIABETIC FOOT 4 0.0013
87 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 2 0.0013
88 LYMPHOEDEMA 9 0.0013
89 REHABILITATION THERAPY 5 0.0013
90 GASTRITIS EROSIVE 6 0.0013
91 INGROWING NAIL 3 0.0013
92 NASAL ULCER 2 0.0013
93 COSTOCHONDRITIS 2 0.0012
94 HAEMATOLOGICAL INFECTION 3 0.0012
95 PERIPHERAL VENOUS DISEASE 5 0.0012
96 RENAL TUBULAR NECROSIS 12 0.0012
97 DERMAL CYST 3 0.0012
98 METASTASES TO PERITONEUM 3 0.0012
99 SUPRAVENTRICULAR EXTRASYSTOLES 4 0.0012
100 BILIARY DYSKINESIA 2 0.0012
101 BLADDER NEOPLASM 2 0.0012
102 ABNORMAL UTERINE BLEEDING 3 0.0012
103 PERIPHERAL VASCULAR DISORDER 6 0.0012
104 MILIARIA 2 0.0012
105 HAEMORRHAGIC STROKE 9 0.0012
106 AORTIC STENOSIS 4 0.0011
107 ALOPECIA AREATA 2 0.0011
108 DECREASED ACTIVITY 12 0.0011
109 OESOPHAGEAL SPASM 2 0.0011
110 EYE OPERATION 5 0.0011
111 NEPHROPATHY 10 0.0011
112 HYPERTENSIVE HEART DISEASE 2 0.0011
113 TIBIA FRACTURE 5 0.0011
114 HYPERTONIC BLADDER 3 0.0010
115 ENTEROCOCCAL INFECTION 5 0.0010
116 OCULAR HYPERTENSION 2 0.0010
117 FAECES HARD 4 0.0010
118 PRODUCT ADMINISTRATION INTERRUPTED 8 0.0010
119 DRUG DELIVERY SYSTEM ISSUE 2 0.0010
120 POLYDIPSIA 4 0.0010
121 CEREBRAL ATROPHY 4 0.0010
122 SKIN PAPILLOMA 4 0.0010
123 DEVICE RELATED SEPSIS 2 0.0010
124 OSTEOPENIA 15 0.0010
125 ISCHAEMIC CARDIOMYOPATHY 3 0.0010
126 GOITRE 4 0.0010
127 IMPAIRED QUALITY OF LIFE 14 0.0010
128 ANAL PRURITUS 2 0.0010
129 PHYSICAL ASSAULT 2 0.0010
130 BREAST CANCER RECURRENT 3 0.0009
131 DEVICE CONNECTION ISSUE 2 0.0009
132 ACUTE RESPIRATORY FAILURE 18 0.0009
133 OVERWEIGHT 5 0.0009
134 LYMPHOCYTE COUNT INCREASED 3 0.0009
135 DIVERTICULUM INTESTINAL 4 0.0009
136 NEAR DEATH EXPERIENCE 3 0.0009
137 DIABETIC NEPHROPATHY 2 0.0009
138 PLANTAR FASCIITIS 3 0.0009
139 APPLICATION SITE URTICARIA 2 0.0009
140 ANAL INCONTINENCE 8 0.0009
141 IRON DEFICIENCY 4 0.0009
142 DIABETIC RETINOPATHY 3 0.0009
143 VASCULAR DEVICE INFECTION 4 0.0009
144 EYE DISCHARGE 9 0.0009
145 DERMATITIS EXFOLIATIVE GENERALISED 3 0.0009
146 LICHEN PLANUS 2 0.0009
147 CAROTID ARTERY STENOSIS 3 0.0009
148 DERMATITIS ATOPIC 45 0.0009
149 PRODUCT DOSE OMISSION IN ERROR 24 0.0008
150 SARCOIDOSIS 4 0.0008
151 HYPERLIPIDAEMIA 10 0.0008
152 LACUNAR INFARCTION 2 0.0008
153 RENAL TRANSPLANT 3 0.0008
154 MONOCYTE COUNT INCREASED 3 0.0008
155 INGUINAL HERNIA 5 0.0008
156 SKIN FISSURES 16 0.0008
157 BONE DENSITY DECREASED 25 0.0008
158 SNORING 3 0.0008
159 ANGLE CLOSURE GLAUCOMA 2 0.0008
160 THYROID MASS 3 0.0008
161 BLOOD CHLORIDE DECREASED 2 0.0008
162 EPIGASTRIC DISCOMFORT 3 0.0008
163 NAIL DISCOLOURATION 3 0.0008
164 PRODUCT PREPARATION ISSUE 5 0.0008
165 RENAL FAILURE 100 0.0008
166 HYPERPHAGIA 3 0.0008
167 AZOTAEMIA 3 0.0008
168 BLEPHARITIS 3 0.0007
169 VITAMIN B12 DEFICIENCY 3 0.0007
170 GAMBLING DISORDER 2 0.0007
171 CHONDROPATHY 2 0.0007
172 MIGRAINE WITH AURA 2 0.0007
173 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 3 0.0007
174 CLUMSINESS 2 0.0007
175 APPLICATION SITE EXFOLIATION 3 0.0007
176 MACULE 2 0.0007
177 VITAMIN D DEFICIENCY 7 0.0007
178 SKIN INFECTION 8 0.0007
179 OSTEOPOROSIS 29 0.0007
180 INTERVERTEBRAL DISC DISORDER 3 0.0007
181 GRANULOCYTOPENIA 4 0.0007
182 IRRITABLE BOWEL SYNDROME 15 0.0007
183 PHARYNGEAL DISORDER 2 0.0007
184 FIBULA FRACTURE 2 0.0007
185 SCIATICA 11 0.0007
186 SKIN WARM 4 0.0007
187 FOOT FRACTURE 13 0.0007
188 DEVICE POWER SOURCE ISSUE 2 0.0007
189 RHINITIS ALLERGIC 3 0.0007
190 CARDIAC PACEMAKER INSERTION 4 0.0007
191 INFUSION SITE REACTION 2 0.0007
192 GOUT 12 0.0007
193 WRIST FRACTURE 8 0.0007
194 METABOLIC ENCEPHALOPATHY 2 0.0007
195 SCRATCH 7 0.0007
196 HIV INFECTION 2 0.0007
197 HEREDITARY ANGIOEDEMA 7 0.0007
198 IRON DEFICIENCY ANAEMIA 6 0.0006
199 PIGMENTATION DISORDER 4 0.0006
200 ROSACEA 3 0.0006
201 FEELING OF DESPAIR 3 0.0006
202 NASAL DRYNESS 4 0.0006
203 VAGINAL INFECTION 3 0.0006
204 INFUSION SITE SWELLING 4 0.0006
205 FOREIGN BODY IN THROAT 2 0.0006
206 VULVOVAGINAL PAIN 3 0.0006
207 PORTAL VEIN THROMBOSIS 2 0.0006
208 ARTERIOSCLEROSIS CORONARY ARTERY 4 0.0006
209 ANEURYSM 3 0.0006
210 APPLICATION SITE SWELLING 3 0.0006
211 SKIN MASS 4 0.0006
212 BONE LOSS 9 0.0006
213 QUALITY OF LIFE DECREASED 8 0.0006
214 ACUTE KIDNEY INJURY 91 0.0006
215 APPLICATION SITE PAIN 13 0.0006
216 IMPAIRED GASTRIC EMPTYING 8 0.0006
217 PRODUCT CONTAINER ISSUE 5 0.0006
218 BENIGN PROSTATIC HYPERPLASIA 3 0.0006
219 LEFT VENTRICULAR FAILURE 2 0.0006
220 SKELETAL INJURY 6 0.0006
221 CERVICAL VERTEBRAL FRACTURE 2 0.0006
222 DERMATITIS 12 0.0006
223 RENAL INJURY 17 0.0006
224 POOR QUALITY PRODUCT ADMINISTERED 6 0.0006
225 LOGORRHOEA 2 0.0006
226 COLD SWEAT 10 0.0006
227 GENERALISED OEDEMA 7 0.0006
228 ANORECTAL DISCOMFORT 3 0.0006
229 MACULOPATHY 2 0.0006
230 FIBRIN D DIMER INCREASED 2 0.0006
231 ERYTHEMA OF EYELID 3 0.0006
232 SKIN LACERATION 6 0.0006
233 COAGULOPATHY 9 0.0005
234 SKIN HAEMORRHAGE 8 0.0005
235 HYPERACUSIS 2 0.0005
236 EYE INFECTION 6 0.0005
237 IMMUNE SYSTEM DISORDER 7 0.0005
238 EMOTIONAL DISTRESS 64 0.0005
239 PERONEAL NERVE PALSY 3 0.0005
240 PARANASAL SINUS HYPERSECRETION 2 0.0005
241 SKIN ATROPHY 3 0.0005
242 OESOPHAGEAL DISORDER 2 0.0005
243 GLAUCOMA 10 0.0005
244 MADAROSIS 6 0.0005
245 APHTHOUS ULCER 4 0.0005
246 APNOEA 4 0.0005
247 PELVIC FRACTURE 4 0.0005
248 KNEE OPERATION 5 0.0005
249 HOSPICE CARE 5 0.0005
250 SINUS HEADACHE 3 0.0005
251 DYSPNOEA EXERTIONAL 19 0.0005
252 OBSTRUCTION 2 0.0005
253 GASTROENTERITIS VIRAL 9 0.0005
254 EYE PAIN 28 0.0005
255 FUNGAL SKIN INFECTION 2 0.0005
256 ENURESIS 2 0.0005
257 NOCTURIA 6 0.0005
258 DEMYELINATION 2 0.0005
259 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
260 HAIR DISORDER 4 0.0005
261 LIMB DISCOMFORT 15 0.0005
262 INFUSION SITE EXTRAVASATION 3 0.0005
263 PULMONARY HYPERTENSION 10 0.0005
264 DRY SKIN 64 0.0005
265 ONYCHOMADESIS 2 0.0005
266 CELLULITIS 24 0.0005
267 CARDIOMYOPATHY 7 0.0005
268 MUSCLE ATROPHY 6 0.0005
269 MUSCLE FATIGUE 2 0.0005
270 FOREIGN BODY SENSATION IN EYES 3 0.0005
271 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
272 ABSCESS LIMB 2 0.0005
273 SKIN HYPERPIGMENTATION 4 0.0005
274 CARDIAC OPERATION 4 0.0005
275 HIATUS HERNIA 6 0.0005
276 ATRIOVENTRICULAR BLOCK FIRST DEGREE 2 0.0005
277 SKIN SWELLING 4 0.0005
278 BIPOLAR DISORDER 5 0.0005
279 POLYP 3 0.0005
280 SPINAL OSTEOARTHRITIS 4 0.0005
281 PARONYCHIA 2 0.0005
282 PHYSICAL DISABILITY 2 0.0005
283 MUSCULOSKELETAL CHEST PAIN 7 0.0005
284 FOOT DEFORMITY 5 0.0005
285 CATHETERISATION CARDIAC 2 0.0005
286 POST-TRAUMATIC STRESS DISORDER 3 0.0004
287 FOREIGN BODY IN REPRODUCTIVE TRACT 4 0.0004
288 MALNUTRITION 5 0.0004
289 BLOOD THYROID STIMULATING HORMONE DECREASED 2 0.0004
290 OBESITY 7 0.0004
291 BLOOD TESTOSTERONE DECREASED 3 0.0004
292 ABDOMINAL HERNIA 2 0.0004
293 DERMATITIS CONTACT 5 0.0004
294 SENSORY DISTURBANCE 7 0.0004
295 UROSEPSIS 4 0.0004
296 ARTHRITIS INFECTIVE 2 0.0004
297 BACK DISORDER 7 0.0004
298 TUBULOINTERSTITIAL NEPHRITIS 8 0.0004
299 SKIN EXFOLIATION 36 0.0004
300 PAPULE 3 0.0004
301 SKIN ULCER 11 0.0004
302 SLEEP DISORDER 30 0.0004
303 ARTERIOSCLEROSIS 4 0.0004
304 OSTEOARTHRITIS 18 0.0004
305 SEASONAL ALLERGY 6 0.0004
306 COVID-19 PNEUMONIA 5 0.0004
307 ENDOMETRIOSIS 2 0.0004
308 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
309 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 20 0.0004
310 FAECES SOFT 3 0.0004
311 MAJOR DEPRESSION 3 0.0004
312 GASTROOESOPHAGEAL REFLUX DISEASE 33 0.0004
313 MOUTH HAEMORRHAGE 3 0.0004
314 PHARYNGEAL SWELLING 4 0.0004
315 CYSTITIS 13 0.0004
316 ENCEPHALOPATHY 10 0.0004
317 BLOOD PRESSURE DIASTOLIC DECREASED 3 0.0004
318 PANCREATIC DISORDER 2 0.0004
319 URINARY INCONTINENCE 12 0.0004
320 HYPERVOLAEMIA 2 0.0004
321 LIGAMENT SPRAIN 4 0.0004
322 FEELING DRUNK 3 0.0004
323 BLADDER DISORDER 4 0.0004
324 ABDOMINAL TENDERNESS 2 0.0004
325 HAIR COLOUR CHANGES 5 0.0004
326 TOOTH EXTRACTION 5 0.0004
327 HYPERNATRAEMIA 2 0.0004
328 DRY EYE 20 0.0004
329 FLUID INTAKE REDUCED 2 0.0004
330 BLOOD POTASSIUM DECREASED 12 0.0004
331 EMPHYSEMA 4 0.0004
332 INITIAL INSOMNIA 4 0.0004
333 CACHEXIA 2 0.0004
334 INFUSION SITE PAIN 5 0.0004
335 CONCUSSION 3 0.0004
336 FAILURE TO THRIVE 2 0.0004
337 RESTLESS LEGS SYNDROME 7 0.0004
338 BRAIN FOG 6 0.0004
339 MULTIPLE ALLERGIES 3 0.0004
340 TRANSFUSION 4 0.0004
341 APPLICATION SITE ERYTHEMA 10 0.0004
342 JOINT STIFFNESS 10 0.0004
343 TOOTH INFECTION 5 0.0004
344 FURUNCLE 3 0.0004
345 JOINT DISLOCATION 4 0.0004
346 RENAL CYST 3 0.0004
347 TRICUSPID VALVE INCOMPETENCE 3 0.0004
348 RENAL PAIN 4 0.0004
349 ATRIAL FLUTTER 3 0.0004
350 HAIR TEXTURE ABNORMAL 5 0.0004
351 UTERINE CANCER 3 0.0004
352 HEPATIC CIRRHOSIS 7 0.0004
353 PHOTOPHOBIA 7 0.0004
354 RHINITIS 3 0.0004
355 BLOOD SODIUM DECREASED 7 0.0004
356 HYPERKALAEMIA 13 0.0004
357 MUSCLE DISORDER 3 0.0004
358 CHEILITIS 2 0.0004
359 DECUBITUS ULCER 3 0.0004
360 SLEEP APNOEA SYNDROME 7 0.0004
361 CORONARY ARTERY DISEASE 11 0.0004
362 ACUTE CORONARY SYNDROME 3 0.0004
363 DENTAL CARIES 4 0.0004
364 GASTRIC ULCER HAEMORRHAGE 2 0.0004
365 INJECTION SITE INJURY 2 0.0004
366 DISCOMFORT 22 0.0004
367 TOOTH DISORDER 8 0.0004
368 POLLAKIURIA 15 0.0004
369 ATRIAL SEPTAL DEFECT 3 0.0004
370 NECK PAIN 20 0.0004
371 MASS 5 0.0004
372 ACUTE PULMONARY OEDEMA 2 0.0004
373 OCULAR DISCOMFORT 4 0.0004
374 INFUSION SITE ERYTHEMA 3 0.0004
375 HEMIPARESIS 6 0.0004
376 DEEP VEIN THROMBOSIS 23 0.0004
377 SINUS DISORDER 7 0.0004
378 MITRAL VALVE INCOMPETENCE 4 0.0004
379 HAEMATOCRIT DECREASED 7 0.0004
380 VITAMIN D DECREASED 3 0.0004
381 INTENTIONAL DOSE OMISSION 10 0.0004
382 SCAB 4 0.0004
383 PSEUDOMONAS INFECTION 3 0.0003
384 BLOOD MAGNESIUM DECREASED 3 0.0003
385 CARDIAC MURMUR 3 0.0003
386 MOUTH SWELLING 2 0.0003
387 HYSTERECTOMY 3 0.0003
388 FALL 115 0.0003
389 TASTE DISORDER 7 0.0003
390 HYPOTHYROIDISM 11 0.0003
391 ANXIETY 98 0.0003
392 ECZEMA 18 0.0003
393 POST PROCEDURAL HAEMORRHAGE 4 0.0003
394 FLUID OVERLOAD 5 0.0003
395 NAIL DISORDER 3 0.0003
396 PERIPHERAL SENSORY NEUROPATHY 2 0.0003
397 SPINAL PAIN 4 0.0003
398 RIB FRACTURE 7 0.0003
399 TOOTH LOSS 7 0.0003
400 BACTERAEMIA 4 0.0003
401 ATAXIA 4 0.0003
402 CHOLECYSTITIS 4 0.0003
403 PRODUCTIVE COUGH 16 0.0003
404 MYOSITIS 3 0.0003
405 OROPHARYNGEAL DISCOMFORT 3 0.0003
406 HEPATITIS B 2 0.0003
407 GANGRENE 2 0.0003
408 HYPOAESTHESIA ORAL 5 0.0003
409 OSTEOMYELITIS 6 0.0003
410 LACRIMATION INCREASED 10 0.0003
411 SKIN DISORDER 11 0.0003
412 BONE DISORDER 6 0.0003
413 PRESYNCOPE 8 0.0003
414 BLOOD THYROID STIMULATING HORMONE INCREASED 3 0.0003
415 CONCOMITANT DISEASE AGGRAVATED 2 0.0003
416 PRODUCT DISTRIBUTION ISSUE 3 0.0003
417 ANKLE FRACTURE 5 0.0003
418 ILEUS 4 0.0003
419 APPLICATION SITE IRRITATION 4 0.0003
420 HAEMATURIA 11 0.0003
421 GAIT DISTURBANCE 61 0.0003
422 SQUAMOUS CELL CARCINOMA 3 0.0003
423 DERMATITIS ALLERGIC 4 0.0003
424 CYANOSIS 5 0.0003
425 MULTIPLE INJURIES 2 0.0003
426 OEDEMA 17 0.0003
427 POST PROCEDURAL COMPLICATION 6 0.0003
428 HYPOXIA 11 0.0003
429 CONSTIPATION 68 0.0003
430 ATELECTASIS 3 0.0003
431 CHROMATURIA 7 0.0003
432 EXPOSURE VIA SKIN CONTACT 8 0.0003
433 APPLICATION SITE VESICLES 2 0.0003
434 DRY MOUTH 25 0.0003
435 SURGERY 18 0.0003
436 COELIAC DISEASE 3 0.0003
437 NEPHROLITHIASIS 14 0.0003
438 SKIN DISCOLOURATION 14 0.0003
439 OSTEONECROSIS 10 0.0003
440 MULTIPLE FRACTURES 5 0.0003
441 DISABILITY 6 0.0003
442 PRODUCT FORMULATION ISSUE 2 0.0003
443 BLISTER 17 0.0003
444 OXYGEN SATURATION DECREASED 17 0.0003
445 APPETITE DISORDER 2 0.0003
446 THERAPEUTIC RESPONSE SHORTENED 10 0.0003
447 EAR INFECTION 8 0.0003
448 SALIVARY HYPERSECRETION 3 0.0003
449 BRAIN INJURY 3 0.0003
450 CARDIAC FAILURE CONGESTIVE 24 0.0003
451 CHOLECYSTITIS CHRONIC 2 0.0003
452 BREAST MASS 2 0.0003
453 BACK PAIN 69 0.0003
454 SINUS CONGESTION 4 0.0003
455 DRY THROAT 3 0.0003
456 LIMB INJURY 8 0.0003
457 RASH ERYTHEMATOUS 14 0.0003
458 MATERNAL EXPOSURE BEFORE PREGNANCY 2 0.0003
459 EAR DISCOMFORT 3 0.0003
460 ASTHMA 33 0.0003
461 PARANOIA 5 0.0003
462 BALANCE DISORDER 25 0.0003
463 ENCEPHALITIS 2 0.0003
464 NEURALGIA 7 0.0003
465 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 15 0.0003
466 APHONIA 4 0.0003
467 PRODUCT ODOUR ABNORMAL 3 0.0003
468 PSORIASIS 37 0.0003
469 SINUS TACHYCARDIA 4 0.0003
470 DIVERTICULUM 2 0.0003
471 RETCHING 6 0.0003
472 JOINT INJURY 6 0.0003
473 AGEUSIA 7 0.0003
474 CONTUSION 27 0.0003
475 FEAR OF INJECTION 2 0.0003
476 ARTHRITIS 22 0.0003
477 GLYCOSYLATED HAEMOGLOBIN INCREASED 7 0.0003
478 PULMONARY ARTERIAL HYPERTENSION 4 0.0003
479 OESOPHAGITIS 3 0.0003
480 NEUROPATHY PERIPHERAL 26 0.0003
481 STAPHYLOCOCCAL INFECTION 9 0.0003
482 ORAL DISORDER 2 0.0003
483 ILLNESS 28 0.0003
484 DYSURIA 10 0.0003
485 CEREBRAL DISORDER 2 0.0003
486 BRONCHITIS 20 0.0003
487 CATARACT 16 0.0003
488 ORAL PAIN 6 0.0003
489 THROAT IRRITATION 12 0.0003
490 HYDRONEPHROSIS 2 0.0003
491 RASH 116 0.0003
492 GASTRITIS 7 0.0003
493 DYSARTHRIA 10 0.0003
494 PAIN IN EXTREMITY 78 0.0003
495 BLOOD URINE PRESENT 5 0.0003
496 RHINORRHOEA 17 0.0003
497 MICTURITION URGENCY 3 0.0003
498 CHOLECYSTECTOMY 3 0.0003
499 INTERNAL HAEMORRHAGE 3 0.0003
500 VISION BLURRED 36 0.0003
501 BOWEL MOVEMENT IRREGULARITY 2 0.0003
502 LIPASE INCREASED 2 0.0003
503 NEOPLASM 3 0.0003
504 EYE IRRITATION 15 0.0003
505 LOWER LIMB FRACTURE 5 0.0003
506 DEVICE RELATED INFECTION 4 0.0003
507 THYROID DISORDER 4 0.0003
508 DEPRESSION 59 0.0003
509 OROPHARYNGEAL PAIN 24 0.0003
510 RASH PRURITIC 14 0.0003
511 ELECTROLYTE IMBALANCE 3 0.0003
512 RASH MACULAR 9 0.0003
513 EPISTAXIS 19 0.0003
514 PRODUCT USE COMPLAINT 4 0.0003
515 PERIPHERAL SWELLING 39 0.0003
516 PRURITUS 97 0.0003
517 PROCEDURAL PAIN 7 0.0003
518 RESPIRATORY TRACT CONGESTION 4 0.0003
519 ACCIDENT 3 0.0003
520 MACULAR DEGENERATION 3 0.0003
521 INTENTIONAL PRODUCT USE ISSUE 22 0.0003
522 HYPERTENSION 53 0.0002
523 OBSESSIVE-COMPULSIVE DISORDER 2 0.0002
524 MOVEMENT DISORDER 8 0.0002
525 PRODUCT DOSE OMISSION ISSUE 73 0.0002
526 LOCALISED INFECTION 6 0.0002
527 TREMOR 41 0.0002
528 THERAPEUTIC RESPONSE UNEXPECTED 11 0.0002
529 BLOOD CREATININE INCREASED 16 0.0002
530 PAIN 150 0.0002
531 GLOMERULAR FILTRATION RATE DECREASED 3 0.0002
532 TENDON RUPTURE 3 0.0002
533 VENTRICULAR TACHYCARDIA 4 0.0002
534 WEIGHT DECREASED 67 0.0002
535 HAEMODIALYSIS 2 0.0002
536 ASCITES 7 0.0002
537 RENAL IMPAIRMENT 20 0.0002
538 TYPE 2 DIABETES MELLITUS 8 0.0002
539 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 13 0.0002
540 HALLUCINATION, VISUAL 5 0.0002
541 HYPOPHAGIA 6 0.0002
542 FACIAL PARALYSIS 2 0.0002
543 COVID-19 41 0.0002
544 ROTATOR CUFF SYNDROME 3 0.0002
545 MUSCLE STRAIN 2 0.0002
546 NODULE 3 0.0002
547 ORTHOSTATIC HYPOTENSION 4 0.0002
548 DEVICE USE ISSUE 4 0.0002
549 URINARY TRACT INFECTION 39 0.0002
550 ORAL CANDIDIASIS 3 0.0002
551 HYPOAESTHESIA 34 0.0002
552 ABNORMAL BEHAVIOUR 9 0.0002
553 FEMUR FRACTURE 7 0.0002
554 ATRIAL FIBRILLATION 22 0.0002
555 MEMORY IMPAIRMENT 31 0.0002
556 SYSTEMIC LUPUS ERYTHEMATOSUS 8 0.0002
557 SEPSIS 25 0.0002
558 FACIAL PAIN 2 0.0002
559 MUSCLE SPASMS 41 0.0002
560 PULMONARY OEDEMA 10 0.0002
561 PAIN OF SKIN 6 0.0002
562 HEAVY MENSTRUAL BLEEDING 2 0.0002
563 PRODUCT TASTE ABNORMAL 3 0.0002
564 COMPLICATION OF DEVICE REMOVAL 4 0.0002
565 TACHYPNOEA 3 0.0002
566 LUPUS-LIKE SYNDROME 2 0.0002
567 PELVIC PAIN 4 0.0002
568 OPTIC NEURITIS 2 0.0002
569 DIARRHOEA 142 0.0002
570 LEUKOPENIA 11 0.0002
571 DECREASED APPETITE 51 0.0002
572 CORONARY ARTERY OCCLUSION 3 0.0002
573 SKIN LESION 6 0.0002
574 PERIPHERAL COLDNESS 3 0.0002
575 RESPIRATORY ARREST 6 0.0002
576 INCREASED TENDENCY TO BRUISE 2 0.0002
577 ABNORMAL DREAMS 6 0.0002
578 NERVE COMPRESSION 2 0.0002
579 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
580 CHEST PAIN 40 0.0002
581 CONJUNCTIVITIS 4 0.0002
582 CHEST DISCOMFORT 22 0.0002
583 HEPATIC STEATOSIS 4 0.0002
584 RENAL DISORDER 10 0.0002
585 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 5 0.0002
586 BACTERIAL INFECTION 4 0.0002
587 DEFORMITY 2 0.0002
588 BLOOD TEST ABNORMAL 3 0.0002
589 FLANK PAIN 2 0.0002
590 MYALGIA 36 0.0002
591 OCULAR HYPERAEMIA 10 0.0002
592 BLOOD PRESSURE DECREASED 14 0.0002
593 EXPIRED PRODUCT ADMINISTERED 7 0.0002
594 GASTRIC ULCER 4 0.0002
595 CONFUSIONAL STATE 34 0.0002
596 MUSCULOSKELETAL DISORDER 4 0.0002
597 ANAEMIA 40 0.0002
598 GAIT INABILITY 7 0.0002
599 ANGINA PECTORIS 6 0.0002
600 ARTHRALGIA 87 0.0002
601 EYE PRURITUS 7 0.0002
602 AFFECT LABILITY 2 0.0002
603 SEPTIC SHOCK 9 0.0002
604 COMPLICATION ASSOCIATED WITH DEVICE 3 0.0002
605 DIZZINESS POSTURAL 2 0.0002
606 FIBROMYALGIA 5 0.0002
607 HAEMORRHOIDS 4 0.0002
608 ORAL HERPES 4 0.0002
609 SINUSITIS 21 0.0002
610 SOMNOLENCE 41 0.0002
611 COUGH 57 0.0002
612 DYSPNOEA 115 0.0002
613 BLOOD PRESSURE INCREASED 31 0.0002
614 VISUAL IMPAIRMENT 25 0.0002
615 PULMONARY MASS 3 0.0002
616 INABILITY TO AFFORD MEDICATION 2 0.0002
617 COLON CANCER 3 0.0002
618 IMMUNODEFICIENCY 3 0.0002
619 BURNING SENSATION 14 0.0002
620 SPINAL FRACTURE 4 0.0002
621 HOT FLUSH 15 0.0002
622 FULL BLOOD COUNT DECREASED 4 0.0002
623 PLEURAL EFFUSION 12 0.0002
624 EYELID PTOSIS 2 0.0002
625 FLUID RETENTION 10 0.0002
626 FATIGUE 153 0.0002
627 INSURANCE ISSUE 3 0.0002
628 HYPOKALAEMIA 9 0.0002
629 TENDONITIS 3 0.0002
630 PRODUCT USE IN UNAPPROVED INDICATION 48 0.0002
631 INFECTION 28 0.0002
632 POOR VENOUS ACCESS 2 0.0002
633 DELUSION 3 0.0002
634 ACUTE MYELOID LEUKAEMIA 3 0.0002
635 SWELLING 18 0.0002
636 BASAL CELL CARCINOMA 3 0.0002
637 HERPES ZOSTER 11 0.0002
638 ROAD TRAFFIC ACCIDENT 8 0.0002
639 INJECTION SITE DISCOMFORT 2 0.0002
640 KNEE ARTHROPLASTY 4 0.0002
641 HEAD INJURY 6 0.0002
642 MIGRAINE 18 0.0002
643 ABSCESS 3 0.0002
644 BREAST PAIN 2 0.0002
645 IMPAIRED WORK ABILITY 4 0.0002
646 DIZZINESS 93 0.0002
647 NIGHT SWEATS 6 0.0002
648 POOR QUALITY SLEEP 4 0.0002
649 HALLUCINATION 14 0.0002
650 WHEEZING 11 0.0002
651 MUSCLE TIGHTNESS 3 0.0002
652 UNEVALUABLE EVENT 14 0.0002
653 MUSCULAR WEAKNESS 21 0.0002
654 BLOOD POTASSIUM INCREASED 3 0.0002
655 PRODUCT DOSE OMISSION 12 0.0002
656 LUNG DISORDER 9 0.0002
657 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
658 INTERVERTEBRAL DISC PROTRUSION 4 0.0002
659 CHOLELITHIASIS 6 0.0002
660 WHITE BLOOD CELL COUNT INCREASED 7 0.0002
661 PNEUMONIA 59 0.0002
662 HOSPITALISATION 28 0.0002
663 GASTROINTESTINAL PAIN 2 0.0002
664 DRUG LEVEL INCREASED 3 0.0002
665 VIRAL INFECTION 6 0.0002
666 FUNGAL INFECTION 6 0.0002
667 STEVENS-JOHNSON SYNDROME 4 0.0002
668 SYNCOPE 18 0.0002
669 NERVE INJURY 2 0.0002
670 BLOOD UREA INCREASED 3 0.0002
671 WOUND 5 0.0002
672 ADVERSE DRUG REACTION 16 0.0002
673 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 32 0.0002
674 INSOMNIA 47 0.0002
675 FLATULENCE 10 0.0002
676 APPLICATION SITE PRURITUS 4 0.0002
677 MYOCARDIAL ISCHAEMIA 2 0.0002
678 INJECTION SITE BRUISING 14 0.0002
679 RED BLOOD CELL COUNT DECREASED 5 0.0002
680 SKIN IRRITATION 8 0.0002
681 HYPERSOMNIA 5 0.0002
682 GASTRIC HAEMORRHAGE 2 0.0002
683 MULTI-ORGAN FAILURE 3 0.0002
684 UPPER RESPIRATORY TRACT INFECTION 8 0.0002
685 METASTASES TO LUNG 2 0.0002
686 DEHYDRATION 23 0.0002
687 OEDEMA PERIPHERAL 21 0.0002
688 HEADACHE 108 0.0002
689 LOCAL SWELLING 3 0.0002
690 DYSSTASIA 5 0.0002
691 DYSPHONIA 10 0.0002
692 ASTHENIA 64 0.0002
693 LYMPHADENOPATHY 6 0.0002
694 PSYCHOTIC DISORDER 5 0.0002
695 DYSPHAGIA 16 0.0002
696 ISCHAEMIC STROKE 3 0.0002
697 THERAPY INTERRUPTED 12 0.0002
698 MYOCLONUS 2 0.0002
699 VOMITING 78 0.0002
700 HEPATITIS C 2 0.0002
701 THERAPEUTIC RESPONSE DECREASED 10 0.0002
702 BURSITIS 2 0.0002
703 HYPOTENSION 33 0.0002
704 TREATMENT NONCOMPLIANCE 9 0.0002
705 RESTLESSNESS 6 0.0002
706 HAEMATOCHEZIA 9 0.0002
707 NAUSEA 129 0.0002
708 DYSPEPSIA 16 0.0002
709 CARDIOMEGALY 2 0.0002
710 THROMBOSIS 13 0.0002
711 PHARYNGITIS 2 0.0002
712 PANCYTOPENIA 9 0.0002
713 THINKING ABNORMAL 3 0.0002
714 ABDOMINAL DISCOMFORT 27 0.0002
715 ERYTHEMA 33 0.0002
716 SWOLLEN TONGUE 5 0.0002
717 FEELING ABNORMAL 38 0.0002
718 FRACTURE 3 0.0002
719 PROTEINURIA 3 0.0002
720 INJECTION SITE IRRITATION 2 0.0002
721 MOOD SWINGS 5 0.0002
722 THERAPY CESSATION 8 0.0002
723 HAEMOGLOBIN DECREASED 16 0.0002
724 HERNIA 3 0.0002
725 METASTASES TO CENTRAL NERVOUS SYSTEM 2 0.0002
726 EAR PAIN 3 0.0002
727 BONE PAIN 9 0.0002
728 CEREBROVASCULAR ACCIDENT 26 0.0002
729 NASAL CONGESTION 9 0.0002
730 ALOPECIA 30 0.0002
731 IMPAIRED HEALING 5 0.0002
732 BEDRIDDEN 2 0.0002
733 EYE DISORDER 5 0.0002
734 DISORIENTATION 6 0.0002
735 HEART RATE INCREASED 15 0.0002
736 CONDITION AGGRAVATED 46 0.0002
737 BLOOD PRESSURE ABNORMAL 3 0.0002
738 DYSMENORRHOEA 2 0.0002
739 RESPIRATORY FAILURE 11 0.0002
740 LIP SWELLING 5 0.0001
741 COGNITIVE DISORDER 7 0.0001
742 MENSTRUATION IRREGULAR 4 0.0001
743 MALIGNANT MELANOMA 2 0.0001
744 JOINT RANGE OF MOTION DECREASED 2 0.0001
745 FEAR 4 0.0001
746 STOMATITIS 9 0.0001
747 DEVICE BREAKAGE 6 0.0001
748 SEIZURE 17 0.0001
749 BODY TEMPERATURE INCREASED 3 0.0001
750 FEELING HOT 9 0.0001
751 ACCIDENTAL EXPOSURE TO PRODUCT 15 0.0001
752 APPLICATION SITE RASH 2 0.0001
753 RESPIRATORY DISTRESS 4 0.0001
754 NIGHTMARE 5 0.0001
755 HYPOGLYCAEMIA 7 0.0001
756 ARTHROPATHY 8 0.0001
757 GASTROINTESTINAL HAEMORRHAGE 12 0.0001
758 HUNGER 2 0.0001
759 INJECTION SITE SWELLING 11 0.0001
760 INFLUENZA 16 0.0001
761 INJECTION SITE PAIN 44 0.0001
762 BLOOD GLUCOSE INCREASED 27 0.0001
763 CARPAL TUNNEL SYNDROME 2 0.0001
764 DEVICE OCCLUSION 2 0.0001
765 DISSEMINATED INTRAVASCULAR COAGULATION 2 0.0001
766 DIALYSIS 2 0.0001
767 ABDOMINAL PAIN UPPER 29 0.0001
768 LIVER FUNCTION TEST INCREASED 3 0.0001
769 HYPERHIDROSIS 18 0.0001
770 SKIN CANCER 3 0.0001
771 LETHARGY 8 0.0001
772 AMNESIA 9 0.0001
773 NEEDLE ISSUE 4 0.0001
774 APATHY 2 0.0001
775 GASTROENTERITIS 2 0.0001
776 LABORATORY TEST ABNORMAL 4 0.0001
777 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
778 THROMBOCYTOPENIA 15 0.0001
779 RASH PAPULAR 3 0.0001
780 SNEEZING 3 0.0001
781 RESPIRATORY DISORDER 4 0.0001
782 INTESTINAL OBSTRUCTION 5 0.0001
783 APHASIA 4 0.0001
784 RHEUMATOID ARTHRITIS 15 0.0001
785 DEVICE FAILURE 2 0.0001
786 VERTIGO 8 0.0001
787 DIABETES MELLITUS 10 0.0001
788 TINNITUS 6 0.0001
789 HIP ARTHROPLASTY 2 0.0001
790 MUSCLE TWITCHING 3 0.0001
791 PHARYNGEAL OEDEMA 2 0.0001
792 LUNG INFECTION 2 0.0001
793 PRODUCT PRESCRIBING ERROR 3 0.0001
794 HALLUCINATION, AUDITORY 2 0.0001
795 INTENTIONAL PRODUCT MISUSE 11 0.0001
796 MUSCULOSKELETAL STIFFNESS 11 0.0001
797 MOBILITY DECREASED 9 0.0001
798 BLOOD PRESSURE FLUCTUATION 3 0.0001
799 BLOOD GLUCOSE DECREASED 6 0.0001
800 ABDOMINAL PAIN 29 0.0001
801 ABDOMINAL DISTENSION 13 0.0001
802 HIP FRACTURE 4 0.0001
803 HYPONATRAEMIA 7 0.0001
804 MENTAL IMPAIRMENT 3 0.0001
805 PSORIATIC ARTHROPATHY 5 0.0001
806 DYSKINESIA 5 0.0001
807 MANIA 2 0.0001
808 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
809 PNEUMONIA ASPIRATION 3 0.0001
810 WHITE BLOOD CELL COUNT DECREASED 13 0.0001
811 URINARY RETENTION 4 0.0001
812 CARDIO-RESPIRATORY ARREST 5 0.0001
813 ABDOMINAL PAIN LOWER 3 0.0001
814 MALAISE 52 0.0001
815 TRANSIENT ISCHAEMIC ATTACK 4 0.0001
816 CANDIDA INFECTION 2 0.0001
817 ANGER 4 0.0001
818 CARDIAC DISORDER 11 0.0001
819 WEIGHT INCREASED 26 0.0001
820 DIPLOPIA 3 0.0001
821 VAGINAL HAEMORRHAGE 5 0.0001
822 NERVOUSNESS 6 0.0001
823 DEAFNESS 3 0.0001
824 MUSCULOSKELETAL PAIN 6 0.0001
825 PARAESTHESIA 18 0.0001
826 AMENORRHOEA 2 0.0001
827 ALANINE AMINOTRANSFERASE INCREASED 7 0.0001
828 HEART RATE DECREASED 4 0.0001
829 INJURY 8 0.0001
830 METASTASES TO LIVER 2 0.0001
831 DEPRESSED MOOD 6 0.0001
832 HYPERSENSITIVITY 21 0.0001
833 ACUTE RESPIRATORY DISTRESS SYNDROME 2 0.0001
834 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
835 ASPARTATE AMINOTRANSFERASE INCREASED 6 0.0001
836 PLATELET COUNT DECREASED 12 0.0001
837 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 8 0.0001
838 CARDIAC FAILURE 9 0.0001
839 GALLBLADDER DISORDER 2 0.0001
840 THERAPY NON-RESPONDER 5 0.0001
841 FREQUENT BOWEL MOVEMENTS 3 0.0001
842 BLOOD BILIRUBIN INCREASED 3 0.0001
843 PALPITATIONS 13 0.0001
844 LEUKOCYTOSIS 2 0.0001
845 CRYING 4 0.0001
846 DISEASE PROGRESSION 13 0.0001
847 ACCIDENTAL OVERDOSE 4 0.0001
848 SUICIDAL IDEATION 10 0.0001
849 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 2 0.0001
850 TREATMENT FAILURE 9 0.0001
851 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 22 0.0001
852 BLOOD GLUCOSE ABNORMAL 2 0.0001
853 DIVERTICULITIS 3 0.0001
854 INJECTION SITE MASS 4 0.0001
855 DEATH 93 0.0001
856 FEELING COLD 3 0.0001
857 DRUG INEFFECTIVE 142 0.0001
858 EYE SWELLING 4 0.0001
859 SWELLING FACE 7 0.0001
860 BLOOD CHOLESTEROL INCREASED 5 0.0001
861 MIDDLE INSOMNIA 2 0.0001
862 PRODUCT USE ISSUE 20 0.0001
863 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
864 PULMONARY EMBOLISM 10 0.0001
865 FEELING JITTERY 2 0.0001
866 INCREASED APPETITE 2 0.0001
867 PRESCRIBED OVERDOSE 2 0.0001
868 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
869 PLASMA CELL MYELOMA 4 0.0001
870 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
871 KIDNEY INFECTION 2 0.0001
872 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
873 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
874 DEVICE ISSUE 9 0.0001
875 PRESCRIBED UNDERDOSE 2 0.0001
876 DEVICE MALFUNCTION 7 0.0001
877 HEPATIC FAILURE 3 0.0001
878 JOINT SWELLING 12 0.0001
879 OFF LABEL USE 87 0.0001
880 FEEDING DISORDER 2 0.0001
881 BLINDNESS 4 0.0001
882 NEUTROPHIL COUNT DECREASED 4 0.0001
883 INJECTION SITE RASH 3 0.0001
884 LUNG NEOPLASM MALIGNANT 4 0.0001
885 NERVOUS SYSTEM DISORDER 3 0.0001
886 PYREXIA 33 0.0001
887 PANCREATITIS 5 0.0001
888 BRADYCARDIA 5 0.0001
889 METABOLIC ACIDOSIS 3 0.0001
890 LOSS OF CONSCIOUSNESS 12 0.0001
891 RECTAL HAEMORRHAGE 4 0.0001
892 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
893 FAECES DISCOLOURED 2 0.0001
894 DEVICE DISLOCATION 4 0.0001
895 MENTAL DISORDER 4 0.0001
896 PRODUCT DISPENSING ERROR 2 0.0001
897 MELAENA 2 0.0001
898 ANGIOEDEMA 4 0.0001
899 HEPATOTOXICITY 2 0.0001
900 INJECTION SITE PRURITUS 6 0.0001
901 GLOSSODYNIA 2 0.0001
902 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
903 GASTROINTESTINAL DISORDER 8 0.0001
904 PANCREATITIS ACUTE 2 0.0001
905 HEART RATE IRREGULAR 2 0.0001
906 HEPATIC ENZYME INCREASED 6 0.0001
907 MALIGNANT NEOPLASM PROGRESSION 9 0.0001
908 PRODUCT AVAILABILITY ISSUE 2 0.0001
909 INJECTION SITE HAEMORRHAGE 7 0.0001
910 GASTRIC DISORDER 3 0.0001
911 INJECTION SITE REACTION 6 0.0001
912 ADVERSE EVENT 8 0.0001
913 NASOPHARYNGITIS 16 0.0001
914 CHILLS 10 0.0001
915 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 6 0.0001
916 CEREBRAL HAEMORRHAGE 3 0.0001
917 SKIN BURNING SENSATION 6 0.0001
918 MULTIPLE SCLEROSIS 4 0.0001
919 IRRITABILITY 5 0.0001
920 DRUG INTOLERANCE 8 0.0001
921 PANIC ATTACK 3 0.0001
922 ILL-DEFINED DISORDER 5 0.0001
923 AGITATION 6 0.0001
924 ABASIA 2 0.0001
925 DYSGEUSIA 6 0.0001
926 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
927 AGGRESSION 4 0.0001
928 COLITIS 3 0.0001
929 HAEMATEMESIS 2 0.0001
930 FLUSHING 8 0.0001
931 URTICARIA 13 0.0001
932 PHARMACEUTICAL PRODUCT COMPLAINT 2 0.0001
933 MUCOSAL INFLAMMATION 2 0.0001
934 SPEECH DISORDER 4 0.0001
935 DEVICE DIFFICULT TO USE 5 0.0001
936 BREAST CANCER 7 0.0001
937 DISTURBANCE IN ATTENTION 4 0.0001
938 PRODUCT QUALITY ISSUE 10 0.0001
939 NEUTROPENIA 10 0.0001
940 PALLOR 2 0.0001
941 PNEUMONITIS 2 0.0001
942 INFLUENZA LIKE ILLNESS 6 0.0001
943 CARDIAC ARREST 6 0.0001
944 MENTAL STATUS CHANGES 2 0.0001
945 MEDICATION ERROR 4 0.0001
946 RHABDOMYOLYSIS 3 0.0001
947 HAEMOPTYSIS 2 0.0001
948 DEMENTIA 2 0.0001
949 WITHDRAWAL SYNDROME 3 0.0001
950 RENAL FAILURE ACUTE 3 0.0001
951 PAIN IN JAW 2 0.0001
952 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
953 INCORRECT DOSE ADMINISTERED 16 0.0001
954 HYPOACUSIS 3 0.0001
955 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
956 PANCREATIC CARCINOMA 2 0.0001
957 GENERAL PHYSICAL HEALTH DETERIORATION 8 0.0001
958 PRODUCT STORAGE ERROR 6 0.0001
959 ACUTE MYOCARDIAL INFARCTION 2 0.0001
960 EMOTIONAL DISORDER 2 0.0001
961 MYOCARDIAL INFARCTION 11 0.0001
962 RENAL CANCER 3 0.0001
963 INTERSTITIAL LUNG DISEASE 3 0.0001
964 DRUG DOSE OMISSION 10 0.0001
965 INFUSION RELATED REACTION 4 0.0001
966 FEBRILE NEUTROPENIA 4 0.0001
967 NEOPLASM MALIGNANT 4 0.0001
968 MULTIPLE SCLEROSIS RELAPSE 4 0.0001
969 INFLAMMATION 3 0.0001
970 DELIRIUM 2 0.0001
971 DRUG WITHDRAWAL SYNDROME 5 0.0001
972 TACHYCARDIA 5 0.0001
973 DRUG EFFECT DECREASED 3 0.0001
974 UNDERDOSE 4 0.0001
975 ANAPHYLACTIC REACTION 3 0.0001
976 BLADDER CANCER 3 0.0001
977 DRUG INTERACTION 8 0.0001
978 SUICIDE ATTEMPT 3 0.0000
979 INJECTION SITE ERYTHEMA 6 0.0000
980 LIVER DISORDER 2 0.0000
981 COLITIS ULCERATIVE 2 0.0000
982 ARRHYTHMIA 2 0.0000
983 COMA 2 0.0000
984 OVERDOSE 9 0.0000
985 HAEMORRHAGE 4 0.0000
986 DRUG DEPENDENCE 5 0.0000
987 NO ADVERSE EVENT 5 0.0000
988 ACNE 2 0.0000
989 DRUG ABUSE 2 0.0000
990 TOXICITY TO VARIOUS AGENTS 4 0.0000